ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 159 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2020. The put-call ratio across all filers is 1.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $3,566,000 | -40.5% | 95,955 | -17.8% | 0.03% | -47.6% |
Q2 2020 | $5,993,000 | -52.2% | 116,804 | -45.7% | 0.06% | -54.7% |
Q1 2020 | $12,538,000 | -2.2% | 215,096 | 0.0% | 0.14% | +1.5% |
Q4 2019 | $12,826,000 | +863.6% | 215,096 | +617.0% | 0.14% | +661.1% |
Q3 2018 | $1,331,000 | +13.2% | 30,000 | 0.0% | 0.02% | -5.3% |
Q2 2018 | $1,176,000 | -45.8% | 30,000 | 0.0% | 0.02% | -48.6% |
Q1 2018 | $2,170,000 | -61.2% | 30,000 | -64.7% | 0.04% | -61.9% |
Q4 2017 | $5,596,000 | +39.6% | 85,000 | +6.2% | 0.10% | +38.6% |
Q3 2017 | $4,010,000 | +23.8% | 80,000 | +14.3% | 0.07% | +14.8% |
Q2 2017 | $3,240,000 | +367.5% | 70,000 | +40.0% | 0.06% | +258.8% |
Q3 2016 | $693,000 | +40.3% | 50,000 | 0.0% | 0.02% | +30.8% |
Q2 2016 | $494,000 | -54.1% | 50,000 | -21.9% | 0.01% | -51.9% |
Q1 2016 | $1,076,000 | -35.6% | 64,000 | -14.7% | 0.03% | -40.0% |
Q4 2015 | $1,670,000 | -29.8% | 75,000 | -25.6% | 0.04% | -22.4% |
Q3 2015 | $2,378,000 | -81.8% | 100,800 | -37.0% | 0.06% | -78.7% |
Q2 2015 | $13,082,000 | -1.2% | 160,000 | +11.9% | 0.27% | +1.9% |
Q1 2015 | $13,245,000 | +495.5% | 143,000 | +160.0% | 0.27% | +480.4% |
Q4 2014 | $2,224,000 | – | 55,000 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 4,468,835 | $20,735,000 | 8.65% |
Altium Capital Management LP | 2,496,524 | $11,584,000 | 3.88% |
Deep Track Capital, LP | 6,000,000 | $27,840,000 | 1.78% |
Paradigm Biocapital Advisors LP | 1,157,246 | $5,370,000 | 1.42% |
Monaco Asset Management SAM | 419,262 | $1,945,000 | 0.77% |
Rhenman & Partners Asset Management AB | 981,582 | $4,555,000 | 0.45% |
PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $12,589,000 | 0.39% |
Bellevue Group AG | 4,299,164 | $19,948,000 | 0.23% |
WASATCH ADVISORS LP | 8,147,380 | $37,804,000 | 0.19% |
Telemetry Investments, L.L.C. | 17,500 | $81,000 | 0.13% |